[Posterior tibial nerve stimulation in overactive bladder]

Alfie V, Soto N, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A
Record ID 32017000295
Spanish
Authors' recommendations: High quality evidence indicates that percutaneous tibial nerve stimulation is as effective, but not better than drugs as third line treatment in patients with overactive bladder and that when both approaches are combined the outcomes are better than single administration of any of them at three-months of treatment. Moderate quality evidence shows that percutaneous tibial nerve stimulation may be used as first line treatment, showing similar results to those obtained with anticholinergic drugs and with less frequent adverse effects. It has not been proven to be better than transvaginal electrical stimulation and there are no studies demonstrating that the effects continue beyond six months. There is scarce high quality evidence showing that transcutaneous posterior tibial nerve stimulation is as effective as drug use for the treatment of overactive bladder, with sustained effect at six-month treatment. This stimulation technique has the advantage of being non-invasive and self-administered by the patient. Percutaneous tibial nerve stimulation is recommended as third line treatment in most clinical practice guidelines surveyed. The healthcare providers from Chile, United Kingdom and United States and the health sponsors from United States cover percutaneous tibial nerve stimulation, but not transcutaneous posterior tibial nerve stimulation.
Details
Project Status: Completed
Year Published: 2017
URL for published report: www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Humans
  • Tibial Nerve
  • Transcutaneous Electric Nerve Stimulation
  • Urinary Bladder, Overactive
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.